Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

Xiamen Amoytop Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	2,587	2,093	1,517	1,123	789.39	725.27
Other Revenue	7.74	7.74	10	9.51	4.54	4.4
Revenue	2,595	2,100	1,527	1,132	793.93	729.67
Revenue Growth (YoY)	40.78%	37.55%	34.86%	42.61%	8.81%	62.77%
Cost of Revenue	179.47	143.16	171.01	126.99	85.65	81.74
Gross Profit	2,416	1,957	1,356	1,005	708.29	647.93
Selling, General & Admin	1,271	1,057	841.02	700.65	503.55	482.54
Research & Development	279	228.52	148.58	79.74	74.23	50.49
Other Operating Expenses	13.56	10.95	7.64	5.55	3.83	3.67
Operating Expenses	1,564	1,297	995.83	783.6	581.42	538.98
Operating Income	852.17	659.88	360.06	221.64	126.86	108.95
Interest Expense	-0.49	-0.51	-0.62	-1.07	-2.46	-3.38
Interest & Investment Income	7.74	10.17	8.09	7.84	3.67	0.45
Currency Exchange Gain (Loss)	-1.03	-1.03	0.48	-0.47	-0.95	-0.01
Other Non Operating Income (Expenses)	33.85	-0.39	-0.25	-0.24	0.39	-5.42
EBT Excluding Unusual Items	892.23	668.13	367.77	227.69	127.51	100.6
Gain (Loss) on Sale of Investments	3.78	2.65	0.4	1.8	3.96	-
Gain (Loss) on Sale of Assets	-0.84	-0.87	0.03	-1.8	-1.13	-0.01
Asset Writedown	-12.76	-12.76	-	-	-	-
Other Unusual Items	-43.68	-16.49	-12.27	-12.4	8.73	-9.58
Pretax Income	838.73	640.65	355.93	215.29	139.07	91.01
Income Tax Expense	98.04	85.21	68.91	34.09	22.5	26.72
Net Income	740.69	555.45	287.02	181.2	116.57	64.29
Net Income to Common	740.69	555.45	287.02	181.2	116.57	64.29
Net Income Growth	62.60%	93.52%	58.40%	55.44%	81.31%	301.76%
Shares Outstanding (Basic)	407	405	404	403	402	357
Shares Outstanding (Diluted)	407	405	404	403	402	357
Shares Change (YoY)	1.35%	0.29%	0.39%	0.18%	12.54%	-10.72%
EPS (Basic)	1.82	1.37	0.71	0.45	0.29	0.18
EPS (Diluted)	1.82	1.37	0.71	0.45	0.29	0.18
EPS Growth	60.43%	92.96%	57.78%	55.17%	61.11%	350.00%
Free Cash Flow	137.62	223.64	143.99	43.85	-26.2	78.48
Free Cash Flow Per Share	0.34	0.55	0.36	0.11	-0.07	0.22
Dividend Per Share	0.410	0.410	0.213	0.100	0.050	0.025
Dividend Growth	92.49%	92.49%	113.00%	100.00%	100.00%	-
Gross Margin	93.08%	93.18%	88.80%	88.78%	89.21%	88.80%
Operating Margin	32.84%	31.42%	23.58%	19.58%	15.98%	14.93%
Profit Margin	28.54%	26.45%	18.80%	16.00%	14.68%	8.81%
Free Cash Flow Margin	5.30%	10.65%	9.43%	3.87%	-3.30%	10.75%
EBITDA	911.2	712.11	403.23	260.33	165.03	146.73
EBITDA Margin	35.11%	33.90%	26.41%	22.99%	20.79%	20.11%
D&A For EBITDA	59.03	52.23	43.17	38.69	38.17	37.78
EBIT	852.17	659.88	360.06	221.64	126.86	108.95
EBIT Margin	32.84%	31.42%	23.58%	19.58%	15.98%	14.93%
Effective Tax Rate	11.69%	13.30%	19.36%	15.83%	16.18%	29.36%
Revenue as Reported	2,595	2,100	1,527	1,132	793.93	729.67
Advertising Expenses	-	4.94	2.94	5.48	6.38	4.79

Source: S&P Capital IQ. Standard template. Financial Sources.